At the time of writing, Globus Medical Inc [GMED] stock is trading at $91.18, up 3.67%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GMED shares have gain 9.30% over the last week, with a monthly amount glided 44.14%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Globus Medical Inc [NYSE: GMED] stock has seen the most recent analyst activity on November 07, 2025, when Truist upgraded its rating to a Buy but kept the price target unchanged to $93 for it. Previously, BofA Securities upgraded its rating to Buy on November 07, 2025, and kept the price target unchanged to $91. BTIG Research downgraded its rating to a Neutral. BofA Securities upgraded its rating to a Neutral but $97 remained the price target by the analyst firm on January 10, 2025. Morgan Stanley upgraded its rating to Overweight for this stock on December 02, 2024, and upped its price target to $100. In a note dated August 07, 2024, Wells Fargo upgraded an Overweight rating on this stock and boosted its target price from $60 to $78.
For the past year, the stock price of Globus Medical Inc fluctuated between $51.79 and $94.93. Currently, Wall Street analysts expect the stock to reach $76 within the next 12 months. Globus Medical Inc [NYSE: GMED] shares were valued at $91.18 at the most recent close of the market. An investor can expect a potential drop of -16.65% based on the average GMED price forecast.
Analyzing the GMED fundamentals
According to Globus Medical Inc [NYSE:GMED], the company’s sales were 2.77B for trailing twelve months, which represents an 22.91% jump. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.1 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.87 points at the first support level, and at 86.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 92.62, and for the 2nd resistance point, it is at 94.05.
Ratios To Look Out For
It is important to note that Globus Medical Inc [NYSE:GMED] has a current ratio of 4.13. As well, the Quick Ratio is 2.47, while the Cash Ratio is 0.8. Considering the valuation of this stock, the price to sales ratio is 4.43, the price to book ratio is 2.79 and price to earnings (TTM) ratio is 29.47.
Transactions by insiders
Recent insider trading involved Huller Kelly, Officer, that happened on Nov 25 ’25 when 7500.0 shares were purchased. Director, Davidar David D completed a deal on Nov 12 ’25 to sell 25000.0 shares. Meanwhile, Director ZARRILLI STEPHEN T sold 25000.0 shares on Nov 11 ’25.
